An extremely viral illness spread by mosquitos, yellow fever is widespread in parts of Africa and South America, and can infect unvaccinated travelers. According to the CDC, about 15% of people who get yellow fever develop serious illness that can lead to bleeding, shock, organ failure, and sometimes death.
Meridian is conducting a clinical research study for an investigational vaccine intended to prevent yellow fever infection.
Eligible participants…
- Must be age 18 to 60
- Will receive an investigation yellow fever vaccine OR an FDA-approved yellow fever vaccine at no cost
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (402) 934-7563.

Submit your information
Study Location
Meridian Clinical Research
3319 N 107th St
Omaha, NE 68134
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2022 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy